Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Journal for Immunotherapy of Cancer|June 13, 2025
Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysisDavid Andreu-Sanz, Lisa Gregor, Emanuele Carlini, et al.
Current Hematologic Malignancy Reports|May 3, 2021
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same JobMelanie Schwerdtfeger, Mohamed-Reda Benmebarek, Stefan Endres, et al.
The Oncologist|December 17, 2009
Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?Sebastian Kobold, Susanna Hegewisch-Becker, Karin Oechsle, et al.
Nature Reviews. Cancer|June 4, 2021
Interleukins in cancer: from biology to therapyDaria Briukhovetska, Janina Dörr, Stefan Endres, et al.
Methods in Cell Biology|January 17, 2025
Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy researchSophia Stock, Luisa Fertig, Vivien Doreen Menkhoff, et al.
Cells|May 22, 2019
Limitations in the Design of Chimeric Antigen Receptors for Cancer TherapyStefan Stoiber, Bruno L Cadilha, Mohamed-Reda Benmebarek, et al.
Human Vaccines & Immunotherapeutics|July 18, 2025
11th Immunotherapy of Cancer conference (ITOC): A meeting reportStefanos Michaelides, Viktoria Hartmann, Volkmar Nüssler, et al.
Immunotherapy|April 29, 2015
Strategies to relieve immunosuppression in pancreatic cancerMax Schnurr, Peter Duewell, Christian Bauer, et al.
Clinical Pharmacology and Therapeutics|November 10, 2019
Challenges in Clinical Trial Design for T Cell-Based Cancer ImmunotherapyStephan F Kruger, Bruno L Cadilha, Michael von Bergwelt-Baildon, et al.
Rare Tumors|December 9, 2010
Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case reportSebastian Kobold, Hartmut Merz, Markus Tiemann, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Journal for Immunotherapy of Cancer|June 13, 2025
Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysisDavid Andreu-Sanz, Lisa Gregor, Emanuele Carlini, et al.
Current Hematologic Malignancy Reports|May 3, 2021
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same JobMelanie Schwerdtfeger, Mohamed-Reda Benmebarek, Stefan Endres, et al.
The Oncologist|December 17, 2009
Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?Sebastian Kobold, Susanna Hegewisch-Becker, Karin Oechsle, et al.
Nature Reviews. Cancer|June 4, 2021
Interleukins in cancer: from biology to therapyDaria Briukhovetska, Janina Dörr, Stefan Endres, et al.
Methods in Cell Biology|January 17, 2025
Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy researchSophia Stock, Luisa Fertig, Vivien Doreen Menkhoff, et al.
Cells|May 22, 2019
Limitations in the Design of Chimeric Antigen Receptors for Cancer TherapyStefan Stoiber, Bruno L Cadilha, Mohamed-Reda Benmebarek, et al.
Human Vaccines & Immunotherapeutics|July 18, 2025
11th Immunotherapy of Cancer conference (ITOC): A meeting reportStefanos Michaelides, Viktoria Hartmann, Volkmar Nüssler, et al.
Immunotherapy|April 29, 2015
Strategies to relieve immunosuppression in pancreatic cancerMax Schnurr, Peter Duewell, Christian Bauer, et al.
Clinical Pharmacology and Therapeutics|November 10, 2019
Challenges in Clinical Trial Design for T Cell-Based Cancer ImmunotherapyStephan F Kruger, Bruno L Cadilha, Michael von Bergwelt-Baildon, et al.
Rare Tumors|December 9, 2010
Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case reportSebastian Kobold, Hartmut Merz, Markus Tiemann, et al.
Pageof 18